Patent · US Active

Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor

US8343989B2 · kind B2 · utility

8Cited by

16References

21Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

James P. Edwards · San Diego, US
David E. Kindrachuk · Encinitas, US
Christopher M. Mapes · Village of La Jolla, US
Daniel J. Pippel · Del Mar, US
Jennifer D. Venable · Solana Beach, US

Key dates

Filing date	Jun 16, 2010
Grant date	Jan 1, 2013
Priority date	—
Expiry date	Jun 16, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/4184
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for H4 receptor activity modulation and for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.